sponsored
PatientsVille.com Logo

PatientsVille

Dyspnoea Side Effects

Drugs Associated with Dyspnoea Side Effect


Although all health products are carefully tested before they are licensed for sale, they can carry various risks. Some side effects may only become evident after a product is in use by the general population.

The following drugs are associated with Dyspnoea (click on the link below to view detailed reports):



DISCLAIMER: ALL DATA PROVIDED AS-IS, refer to terms of use for additional information.

Dyspnoea Reports Submitted to FDA

The following Dyspnoea Side Effect Reports were submitted to FDA by healthcare professionals (physicians, pharmacists, and nurses), consumers (patients, family members, and lawyers) and manufacturers.

This information could help you understand how symptoms, such as Dyspnoea could occur, develop and what you can do about them.

Device Failure, Coronary Artery Occlusion, Feeling Abnormal, Diabetes Mellitus, Carotid Artery Occlusion, Dyspnoea, Chest Discomfort

This is a report of a female patient (weight: NA) from UNITED STATES, suffering from the following symptoms/conditions: rheumatoid arthritis, who was treated with Humira (dosage: NA, start time: May 13, 2012), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Device Failure
  • Coronary Artery Occlusion
  • Feeling Abnormal
  • Diabetes Mellitus
  • Carotid Artery Occlusion
  • Dyspnoea
  • Chest Discomfort
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Humira treatment in female patients, resulting in Dyspnoea side effect. The patient was hospitalized.
Dry Mouth, Dyspnoea

This report suggests a potential Spiriva Dry Mouth, Dyspnoea side effect(s) that can have serious consequences. A patient (weight: NA) from UNITED STATES was diagnosed with the following symptoms/conditions: chronic obstructive pulmonary disease,hypertension,cardiac failure congestive,prophylaxis and used Spiriva (dosage: 18 Mcg) starting Jan 01, 2011. Soon after starting Spiriva the patient began experiencing various side effects, including:
  • Dry Mouth
  • Dyspnoea
Drugs used concurrently:
  • Lisinopril (20 Mg)
  • Lasix
  • Coumadin (4 Mg)
  • Advair Diskus 100/50 (2 Puf)
  • Metoprolol Tartrate (200 Mg)
  • Gentamicin (5 Ml)
  • Januvia (100 Mg)
  • Digoxin (10 Mg)
Although Spiriva demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Dyspnoea, may still occur.
Dyspnoea, Oedema

This Dyspnoea, Oedema problem was reported by a physician from UNITED STATES. A 77-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: pulmonary hypertension. On NS this consumer started treatment with Letairis (dosage: Unk). The following drugs were being taken at the same time:
  • Remodulin (Unk)
  • Adcirca (Unk)
When commencing Letairis, the patient experienced the following unwanted symptoms/side effects:
  • Dyspnoea
  • Oedema
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Dyspnoea, may become evident only after a product is in use by the general population.
Heart Rate Increased, Dyspnoea, Infusion Related Reaction, Flushing, Tremor

This is a report of a female patient (weight: NA) from CANADA. The patient developed the following symptoms/conditions: crohn's disease and was treated with Remicade (dosage: In Induction Doses 0-2) starting Jun 19, 2012. Concurrently used drugs:
  • Acetaminophen
Soon after that, the consumer experienced the following side effects:
  • Heart Rate Increased
  • Dyspnoea
  • Infusion Related Reaction
  • Flushing
  • Tremor
This opens a possibility that Remicade treatment could cause the above reactions, including Dyspnoea, and some female subjects may be more susceptible.
Ventricular Dyskinesia, Anxiety, Insomnia, Antisocial Behaviour, Tachycardia, Acute Myocardial Infarction, Intracardiac Thrombus, Palpitations, Dyspnoea

A 73-year-old female patient (weight: NA) from ITALY with the following symptoms/conditions: arthralgia started Vioxx treatment (dosage: NA) on Nov 19, 2003. Soon after starting Vioxx treatment, the subject experienced various side effects, including:
  • Ventricular Dyskinesia
  • Anxiety
  • Insomnia
  • Antisocial Behaviour
  • Tachycardia
  • Acute Myocardial Infarction
  • Intracardiac Thrombus
  • Palpitations
  • Dyspnoea
Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Vioxx.
Bronchitis, Asthma, Dyspnoea

A 52-year-old female patient from UNITED STATES (weight: NA) experienced symptoms, such as: bronchitis chronic and was treated with Advair Diskus 100/50(dosage: 1puff Twice Per Day). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
  • Bronchitis
  • Asthma
  • Dyspnoea
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Advair Diskus 100/50 efficacy:
  • Sertraline Hydrochloride
  • Folic Acid
  • Zinc Sulfate
  • Levoxyl
  • Aspirin
  • Pramipexole Dihychloride
  • Centrum
The patient was hospitalized.
Lung Neoplasm, Dyspnoea

In this report, Enbrel was administered for the following condition: rheumatoid arthritis.A 65-year-old female consumer from UNITED STATES (weight: NA) started Enbrel treatment (dosage: 50 Mg, Qwk) on Jan 01, 2006.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Lung Neoplasm
  • Dyspnoea
A possible interaction with other drugs could have contributed to this reaction: NA.The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Enbrel treatment could be related to the listed above side effect(s).
Chronic Obstructive Pulmonary Disease, Bronchitis Chronic, Sputum Retention, Pneumonia, Dyspnoea, Emphysema

This is a report of the following Symbicort side effect(s):
  • Chronic Obstructive Pulmonary Disease
  • Bronchitis Chronic
  • Sputum Retention
  • Pneumonia
  • Dyspnoea
  • Emphysema
A 79-year-old female patient from UNITED STATES (weight: NA) presented with the following condition: emphysema and received a treatment with Symbicort (dosage: NA) starting: NS.The following concurrently used drugs could have generated interactions:
  • Spiriva
This report suggests that a Symbicort treatment could be associated with the listed above side effect(s).
Upper Limb Fracture, Chest Pain, Dyspnoea

This Avandia report was submitted by a 64-year-old female consumer from UNITED STATES (weight: NA). The patient was diagnosed with: type 2 diabetes mellitus and Avandia was administered (dosage: 8mg Per Day) starting: Jan 01, 2001. The consumer developed a set of symptoms:
  • Upper Limb Fracture
  • Chest Pain
  • Dyspnoea
Other drugs used simultaneously: NA.The patient was hospitalized.Those unexpected symptoms could be linked to a Avandia treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.
Incoherent, Flushing, Rash Erythematous, Vomiting, Nausea, Dyspnoea, Tremor, Chills

This is a report of a possible correlation between Tysabri use and the following symptoms/side effect(s):
  • Incoherent
  • Flushing
  • Rash Erythematous
  • Vomiting
  • Nausea
  • Dyspnoea
  • Tremor
  • Chills
which could contribute to an assessment of Tysabri risk profile.A 44-year-old consumer from UNITED STATES (weight: NA) was suffering from multiple sclerosis and was treated with Tysabri (dosage: NA) starting Feb 21, 2012.Other concurrent medications: NA.
Hyperhidrosis, Dyspnoea, Pain, Skin Discolouration

A patient from UNITED STATES (weight: NA) presented with the following symptoms: thrombosis and after a treatment with Heparin (dosage: NA) experienced the following side effect(s):
  • Hyperhidrosis
  • Dyspnoea
  • Pain
  • Skin Discolouration
The treatment was started on Feb 04, 2012. Heparin was used in combination with the following drugs: NA.This report could alert potential Heparin consumers.
Dyspnoea, Cardiac Failure Congestive, Cough, Fluid Retention

In this report, a 71-year-old female patient from US (weight: NA) was affected by a possible Tracleer side effect.The patient was diagnosed with pulmonary arterial hypertension. After a treatment with Tracleer (dosage: Oral, start date: Aug 31, 2006), the patient experienced the following side effect(s):
  • Dyspnoea
  • Cardiac Failure Congestive
  • Cough
  • Fluid Retention
The following simultaneously used drugs could have led to this reaction:
  • Ventavis (Respiratory)
  • Revatio
  • Calcium Channel Blockers
The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Tracleer treatment.
Surgery, Dyspnoea, Sinus Operation, Hypertension

This is a report of a patient from UNITED STATES (weight: NA), who used Chantix (dosage: 0.5 Mg, Daily) for a treatment of tobacco user. After starting a treatment on Oct 12, 2011, the patient experienced the following side effect(s):
  • Surgery
  • Dyspnoea
  • Sinus Operation
  • Hypertension
The following drugs could possibly have interacted with the Chantix treatment NA.Taken together, these observations suggest that a Chantix treatment could be related to side effect(s), such as Surgery, Dyspnoea, Sinus Operation, Hypertension.
Arthritis Infective, Joint Irrigation, Knee Arthroplasty, Thrombosis, Arthralgia, Dyspnoea

This Dyspnoea side effect was reported by a physician from UNITED STATES. A 52-year-old female patient (weight:NA) experienced the following symptoms/conditions: multiple sclerosis. The patient was prescribed Avonex (dosage: NA), which was started on Sep 27, 2007. Concurrently used drugs: NA. When starting to take Avonex the consumer reported the following symptoms:
  • Arthritis Infective
  • Joint Irrigation
  • Knee Arthroplasty
  • Thrombosis
  • Arthralgia
  • Dyspnoea
The patient was hospitalized. These side effects may potentially be related to Avonex.
Dyspnoea, Abdominal Pain Upper, Pyrexia, Back Pain, Muscle Spasms, Constipation, Musculoskeletal Pain, Musculoskeletal Chest Pain

This is a Revlimid side effect report of a 59-year-old female patient (weight:NA) from UNITED STATES, suffering from the following symptoms/conditions: multiple myeloma, who was treated with Revlimid (dosage:25 Mg Daily For 21 Days, Oral 20 Mg Daily For 21 Days, Oral, start time: May 01, 2010), combined with: NA., and developed a serious reaction and a Dyspnoea side effect. The patient presented with:
  • Dyspnoea
  • Abdominal Pain Upper
  • Pyrexia
  • Back Pain
  • Muscle Spasms
  • Constipation
  • Musculoskeletal Pain
  • Musculoskeletal Chest Pain
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Revlimid treatment in female patients suffering from multiple myeloma, resulting in Dyspnoea.
Dyspnoea

This report suggests a potential Lyrica Dyspnoea side effect(s) that can have serious consequences. A female patient from UNITED STATES (weight:NA) was diagnosed with the following health condition(s): neuralgia and used Lyrica (dosage: 50 Mg, Once In The Morning And 100mg Once In The Evening) starting Jan 01, 2012. Soon after starting Lyrica the patient began experiencing various side effects, including:
  • Dyspnoea
Drugs used concurrently:
  • Acetylsalicylic Acid (Unk)
  • Crestor (5 Mg, Unk)
  • Lopressor (100 Mg, 1x/day)
  • Plavix (75 Mg, Unk)
  • Lasix (40 Mg, 1x/day)
  • Lisinopril (Unk, 1x/day)
The patient was hospitalized. Although Lyrica demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Dyspnoea, may still occur.
Dyspnoea, Hyperhidrosis, Flushing, Abdominal Pain

This Dyspnoea problem was reported by a pharmacist from UNITED STATES. A 57-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): ill-defined disorder.On Feb 13, 2012 a consumer started treatment with Xolair (dosage: 150mg Q4 Weeks Sq). The following drugs/medications were being taken at the same time: NA. When commencing Xolair, the patient experienced the following unwanted symptoms /side effects:
  • Dyspnoea
  • Hyperhidrosis
  • Flushing
  • Abdominal Pain
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Dyspnoea, may become evident only after a product is in use by the general population.
Dyspnoea, Vision Blurred

This is a Forteo side effect report of a 65-year-old female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: osteoporosis and was treated with Forteo (dosage: 20 Mcg Qd Sc) starting Jun 26, 2012. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Dyspnoea
  • Vision Blurred
This opens a possibility that Forteo could cause Dyspnoea and that some female patients may be more susceptible.
Mood Altered, Frustration, Dyspnoea, Agitation, Anger, Dysgeusia, Abnormal Dreams

A female patient (weight: NA) from UNITED STATES with the following symptoms: asthma,dementia alzheimer's type,sleep disorder,thyroid disorder started Combivent treatment (dosage: Unk, 1x/day) on Feb 01, 2012. Soon after starting Combivent treatment, the consumer experienced several side effects, including:
  • Mood Altered
  • Frustration
  • Dyspnoea
  • Agitation
  • Anger
  • Dysgeusia
  • Abnormal Dreams
. Concurrently used drugs:
  • Exelon (9.5 Mg, Unk)
  • Hydroxyzine (10 Mg, 2x/day As Needed)
  • Synthroid (50 Ug, Unk)
  • Namenda (10 Mg, 2x/day)
  • Xalatan (Unk)
  • Prevident (Unk)
  • Caltrate 600+d (Unk, 1x/day)
  • Ondansetron (8 Mg, 4x/day)
This finding indicates that some patients can be more vulnerable to developing Combivent side effects, such as Dyspnoea.
Ear Congestion, Tachycardia, Asthenia, Hypoglycaemia, Diarrhoea, Dizziness, Dry Mouth, Tremor, Dyspnoea

This Dyspnoea side effect was reported by a consumer or non-health professional from BRAZIL. A 45-year-old female patient (weight:NA) experienced the following symptoms/conditions: bronchitis,pharyngeal inflammation.The patient was prescribed Avelox (dosage: NA), which was started on Jun 09, 2012. Concurrently used drugs: NA..When starting to take Avelox the consumer reported symptoms, such as:
  • Ear Congestion
  • Tachycardia
  • Asthenia
  • Hypoglycaemia
  • Diarrhoea
  • Dizziness
  • Dry Mouth
  • Tremor
  • Dyspnoea
These side effects may potentially be related to Avelox.
Urticaria, Pruritus, Dyspnoea, Headache, Sneezing, Erythema, Ear Discomfort, Throat Tightness

This is a report of a 36-year-old female patient (weight: NA) from AUSTRALIA, suffering from the following symptoms/conditions: computerised tomogram abdomen, who was treated with Ultravist 150 (dosage: 60 Ml, Once, start time: Jun 22, 2012), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Urticaria
  • Pruritus
  • Dyspnoea
  • Headache
  • Sneezing
  • Erythema
  • Ear Discomfort
  • Throat Tightness
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ultravist 150 treatment in female patients, resulting in Dyspnoea side effect.
Dyspnoea, Off Label Use, Asthenia, Coronary Artery Occlusion

This report suggests a potential Nexium Dyspnoea, Off Label Use, Asthenia, Coronary Artery Occlusion side effect(s) that can have serious consequences. A 69-year-old female patient (weight: NA) from BRAZIL was diagnosed with the following symptoms/conditions: helicobacter infection,coronary artery occlusion and used Nexium (dosage: NA) starting Jan 01, 2011. Soon after starting Nexium the patient began experiencing various side effects, including:
  • Dyspnoea
  • Off Label Use
  • Asthenia
  • Coronary Artery Occlusion
Drugs used concurrently:
  • Brilinta
Although Nexium demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Dyspnoea, may still occur.
Arterial Occlusive Disease, Myocardial Infarction, Malaise, Dyspnoea, Blood Cholesterol Increased, Anxiety

This Arterial Occlusive Disease, Myocardial Infarction, Malaise, Dyspnoea, Blood Cholesterol Increased, Anxiety problem was reported by a physician from UNITED STATES. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: multiple sclerosis. On Mar 09, 2012 this consumer started treatment with Rebif (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Rebif, the patient experienced the following unwanted symptoms/side effects:
  • Arterial Occlusive Disease
  • Myocardial Infarction
  • Malaise
  • Dyspnoea
  • Blood Cholesterol Increased
  • Anxiety
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Dyspnoea, may become evident only after a product is in use by the general population.
Hypersensitivity, Dysgeusia, Pharyngeal Oedema, Dyspnoea, Gastrointestinal Disorder

This is a report of a 57-year-old female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: type 2 diabetes mellitus and was treated with Byetta (dosage: 5 Ug, Bid, Subcutaneous) starting NS. Concurrently used drugs:
  • Insulin
Soon after that, the consumer experienced the following side effects:
  • Hypersensitivity
  • Dysgeusia
  • Pharyngeal Oedema
  • Dyspnoea
  • Gastrointestinal Disorder
This opens a possibility that Byetta treatment could cause the above reactions, including Dyspnoea, and some female subjects may be more susceptible.
Urticaria, Dyspnoea, Heart Rate Abnormal, Ocular Hyperaemia, Hypersensitivity, Cyanosis

A 59-year-old patient (weight: NA) from UNITED STATES with the following symptoms/conditions: nuclear magnetic resonance imaging brain started Magnevist treatment (dosage: Unk) on Jun 12, 2012. Soon after starting Magnevist treatment, the subject experienced various side effects, including:
  • Urticaria
  • Dyspnoea
  • Heart Rate Abnormal
  • Ocular Hyperaemia
  • Hypersensitivity
  • Cyanosis
Concurrently used drugs: NA. This finding indicates that some patients could be more vulnerable to Magnevist.
Dyspnoea

A 51-year-old patient from UNITED STATES (weight: NA) experienced symptoms, such as: oedema peripheral and was treated with Aleve (caplet)(dosage: Daily Dose 1320 Mg). The treatment was initiated on May 05, 2012. After that a consumer reported the following side effect(s):
  • Dyspnoea
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Aleve (caplet) efficacy: NA.
Arthralgia, Anxiety, Dyspnoea, Back Pain

In this report, Gilenya was administered for the following condition: multiple sclerosis.A 45-year-old female consumer from US (weight: NA) started Gilenya treatment (dosage: NA) on Jan 05, 2011.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Arthralgia
  • Anxiety
  • Dyspnoea
  • Back Pain
A possible interaction with other drugs could have contributed to this reaction:
  • Prednisone (prednisone)
  • Xanax (alprazolam)
  • Lortab (hydrocodone Bitartrate, Paracetamol)
  • Lidoderm (lidocaine)
  • Lyrica (pregabalin)
  • Vitamin D (ergocalciferol)
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Gilenya treatment could be related to the listed above side effect(s).
Angioedema, Dyspnoea

This is a report of the following Lisinopril And Hydrochlorothiazide side effect(s):
  • Angioedema
  • Dyspnoea
A 59-year-old patient from UNITED STATES (weight: NA) presented with the following condition: hypertension and received a treatment with Lisinopril And Hydrochlorothiazide (dosage: 1 Tab Every Day Po) starting: Dec 09, 2011.The following concurrently used drugs could have generated interactions: NA.The patient was hospitalized.This report suggests that a Lisinopril And Hydrochlorothiazide treatment could be associated with the listed above side effect(s).
Dyspnoea, Off Label Use, Condition Aggravated

This Pulmicort Flexhaler report was submitted by a 41-year-old consumer from UNITED STATES (weight: NA). The patient was diagnosed with: upper respiratory tract inflammation,bronchitis and Pulmicort Flexhaler was administered (dosage: 180 Mcg, Two Puffs, Two Times A Day) starting: Jan 01, 2012. The consumer developed a set of symptoms:
  • Dyspnoea
  • Off Label Use
  • Condition Aggravated
Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Pulmicort Flexhaler treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.
Dyspnoea, Hypocalcaemia, Gait Disturbance, Hypokalaemia

This is a report of a possible correlation between Pegasys use and the following symptoms/side effect(s):
  • Dyspnoea
  • Hypocalcaemia
  • Gait Disturbance
  • Hypokalaemia
which could contribute to an assessment of Pegasys risk profile.A 64-year-old female consumer from UNITED STATES (weight: NA) was suffering from hepatitis c and was treated with Pegasys (dosage: 180mcg Qw Sq) starting Mar 15, 2012.Other concurrent medications:
  • Ribavirin (600mg Bid Po)
The patient was hospitalized.
Rash, Rectal Haemorrhage, Cerebral Haemorrhage, Dyspnoea, Pharyngeal Oedema

A patient from UNITED STATES (weight: NA) presented with the following symptoms: back pain,muscle strain,convulsion and after a treatment with Celebrex (dosage: 200 Mg, 2x/day) experienced the following side effect(s):
  • Rash
  • Rectal Haemorrhage
  • Cerebral Haemorrhage
  • Dyspnoea
  • Pharyngeal Oedema
The treatment was started on Jan 01, 2010. Celebrex was used in combination with the following drugs: NA.This report could alert potential Celebrex consumers.
Hypocalcaemia, Renal Failure, Hyperglycaemia, Neurological Decompensation, Multi-organ Failure, Pancytopenia, Asthenia, Dyspnoea, Encephalopathy

In this report, a 72-year-old patient from SPAIN (weight: NA) was affected by a possible Afinitor side effect.The patient was diagnosed with bronchial carcinoma. After a treatment with Afinitor (dosage: 10 Mg, Qd, start date: Aug 22, 2011), the patient experienced the following side effect(s):
  • Hypocalcaemia
  • Renal Failure
  • Hyperglycaemia
  • Neurological Decompensation
  • Multi-organ Failure
  • Pancytopenia
  • Asthenia
  • Dyspnoea
  • Encephalopathy
The following simultaneously used drugs could have led to this reaction: NA.The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Afinitor treatment.
Dyspnoea, Memory Impairment, Platelet Count Decreased, Nausea, White Blood Cell Count Decreased, Aphagia, Swelling Face, Nephritis

This is a report of a patient from UNITED STATES (weight: NA), who used Incivek (dosage: NA) for a treatment of hepatitis c. After starting a treatment on Feb 10, 2012, the patient experienced the following side effect(s):
  • Dyspnoea
  • Memory Impairment
  • Platelet Count Decreased
  • Nausea
  • White Blood Cell Count Decreased
  • Aphagia
  • Swelling Face
  • Nephritis
The following drugs could possibly have interacted with the Incivek treatment
  • Ribavirin
  • Cholestyramine
  • Pegasys
  • Ribavirin
  • Pegasys
  • Fluoxetine
  • Hydrocodone Bitartrate
  • Temazepam
The patient was hospitalized.Taken together, these observations suggest that a Incivek treatment could be related to side effect(s), such as Dyspnoea, Memory Impairment, Platelet Count Decreased, Nausea, White Blood Cell Count Decreased, Aphagia, Swelling Face, Nephritis.
Hypoaesthesia, Paraesthesia, Sinusitis, Influenza Like Illness, Hyperhidrosis, Sinus Congestion, Dyspnoea, Malaise, Pyrexia

This Dyspnoea side effect was reported by a consumer or non-health professional from UNITED STATES. A 52-year-old female patient (weight:NA) experienced the following symptoms/conditions: mental disorder. The patient was prescribed Seroquel (dosage: NA), which was started on NS. Concurrently used drugs: NA. When starting to take Seroquel the consumer reported the following symptoms:
  • Hypoaesthesia
  • Paraesthesia
  • Sinusitis
  • Influenza Like Illness
  • Hyperhidrosis
  • Sinus Congestion
  • Dyspnoea
  • Malaise
  • Pyrexia
These side effects may potentially be related to Seroquel.
Eyelid Oedema, Dyspnoea, Periorbital Haematoma, Swelling Face, Dysphagia

This is a Aspirin side effect report of a 27-year-old patient (weight:NA) from UNITED STATES, suffering from the following symptoms/conditions: toothache, who was treated with Aspirin (dosage:2 Tablets 1 Week Ago Then One Every Other Day Until 2 Nights Ago, start time: Jun 01, 2012), combined with: NA., and developed a serious reaction and a Dyspnoea side effect. The patient presented with:
  • Eyelid Oedema
  • Dyspnoea
  • Periorbital Haematoma
  • Swelling Face
  • Dysphagia
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Aspirin treatment in patients suffering from toothache, resulting in Dyspnoea.
Spinal Disorder, Rotator Cuff Syndrome, Swelling Face, Stasis Dermatitis, Oesophageal Stenosis, Dyspnoea, Nephrolithiasis, Acetabulum Fracture, Haemorrhagic Anaemia

This report suggests a potential Fosamax Dyspnoea side effect(s) that can have serious consequences. A 65-year-old female patient from UNITED STATES (weight:NA) was diagnosed with the following health condition(s): osteoporosis and used Fosamax (dosage: NA) starting Sep 09, 2002. Soon after starting Fosamax the patient began experiencing various side effects, including:
  • Spinal Disorder
  • Rotator Cuff Syndrome
  • Swelling Face
  • Stasis Dermatitis
  • Oesophageal Stenosis
  • Dyspnoea
  • Nephrolithiasis
  • Acetabulum Fracture
  • Haemorrhagic Anaemia
Drugs used concurrently:NA. The patient was hospitalized and became disabled. Although Fosamax demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Dyspnoea, may still occur.
Angina Pectoris, Dyspnoea, Off Label Use, Face Injury, Wound Haemorrhage

This Dyspnoea problem was reported by a consumer or non-health professional from BRAZIL. A 52-year-old patient (weight: NA) was diagnosed with the following medical condition(s): blood cholesterol increased,preoperative care.On Feb 01, 2012 a consumer started treatment with Crestor (dosage: NA). The following drugs/medications were being taken at the same time:
  • Brilinta
When commencing Crestor, the patient experienced the following unwanted symptoms /side effects:
  • Angina Pectoris
  • Dyspnoea
  • Off Label Use
  • Face Injury
  • Wound Haemorrhage
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Dyspnoea, may become evident only after a product is in use by the general population.
Fatigue, Dyspnoea, Dizziness

This is a Lipitor side effect report of a 54-year-old female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: blood cholesterol increased,arrhythmia,restless legs syndrome and was treated with Lipitor (dosage: NA) starting Mar 01, 2011. Concurrently used drugs:
  • Metoprolol Tartrate
  • Clonazepam
  • Estradiol
  • Levothyroxine Sodium
Soon after that, the consumer experienced the following of symptoms:
  • Fatigue
  • Dyspnoea
  • Dizziness
This opens a possibility that Lipitor could cause Dyspnoea and that some female patients may be more susceptible.
Respiratory Distress, Dyspnoea

A 58-year-old patient (weight: NA) from FRANCE with the following symptoms: renal cancer metastatic started Sutent treatment (dosage: 50 Mg, 1x/day) on Dec 18, 2008. Soon after starting Sutent treatment, the consumer experienced several side effects, including:
  • Respiratory Distress
  • Dyspnoea
. Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Sutent side effects, such as Dyspnoea.
Dyspnoea, Depressed Level Of Consciousness, Unresponsive To Stimuli, Hypoventilation

This Dyspnoea side effect was reported by a health professional from UNITED STATES. A patient (weight:NA) experienced the following symptoms/conditions: pain.The patient was prescribed Fentanyl-100 (dosage: One Patch Every 48 Hours), which was started on Apr 16, 2012. Concurrently used drugs: NA..When starting to take Fentanyl-100 the consumer reported symptoms, such as:
  • Dyspnoea
  • Depressed Level Of Consciousness
  • Unresponsive To Stimuli
  • Hypoventilation
These side effects may potentially be related to Fentanyl-100.


Discuss Dyspnoea Side Effects